KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) EBT Margin (2016 - 2025)

Exact Sciences (EXAS) has disclosed EBT Margin for 16 consecutive years, with 9.69% as the latest value for Q4 2025.

  • On a quarterly basis, EBT Margin rose 11310.0% to 9.69% in Q4 2025 year-over-year; TTM through Dec 2025 was 6.28%, a 3128.0% increase, with the full-year FY2025 number at 6.28%, up 3128.0% from a year prior.
  • EBT Margin was 9.69% for Q4 2025 at Exact Sciences, down from 2.09% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 0.17% in Q3 2023 to a low of 122.78% in Q4 2024.
  • A 5-year average of 26.04% and a median of 15.65% in 2024 define the central range for EBT Margin.
  • Peak YoY movement for EBT Margin: plummeted -11500bps in 2024, then skyrocketed 11310bps in 2025.
  • Exact Sciences' EBT Margin stood at 47.46% in 2021, then surged by 50bps to 23.5% in 2022, then surged by 67bps to 7.79% in 2023, then tumbled by -1477bps to 122.78% in 2024, then soared by 92bps to 9.69% in 2025.
  • Per Business Quant, the three most recent readings for EXAS's EBT Margin are 9.69% (Q4 2025), 2.09% (Q3 2025), and 0.01% (Q2 2025).